These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20409426)

  • 21. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
    Dean AC; London ED; Sugar CA; Kitchen CM; Swanson AN; Heinzerling KG; Kalechstein AD; Shoptaw S
    Drug Alcohol Depend; 2009 Nov; 105(1-2):48-55. PubMed ID: 19608354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of executive and memory function associated with amphetamine and opiate dependence.
    Ersche KD; Clark L; London M; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2006 May; 31(5):1036-47. PubMed ID: 16160707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women.
    van der Plas EA; Crone EA; van den Wildenberg WP; Tranel D; Bechara A
    J Clin Exp Neuropsychol; 2009 Aug; 31(6):706-19. PubMed ID: 19037812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.
    Fitzpatrick RE; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Drug Alcohol Depend; 2020 Apr; 209():107891. PubMed ID: 32061948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention and memory in illicit amphetamine users: comparison with non-drug-using controls.
    McKetin R; Mattick RP
    Drug Alcohol Depend; 1998 Apr; 50(2):181-4. PubMed ID: 9649970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning.
    Morgan EE; Doyle KL; Minassian A; Henry BL; Perry W; Marcotte TD; Woods SP; Grant I;
    Psychiatry Res; 2014 Dec; 220(1-2):527-34. PubMed ID: 25081313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology.
    Jaffe C; Bush KR; Straits-Troster K; Meredith C; Romwall L; Rosenbaum G; Cherrier M; Saxon AJ
    J Addict Dis; 2005; 24(3):133-52. PubMed ID: 16186089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.
    Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler M; Gatley SJ; Miller E; Hitzemann R; Ding YS; Logan J
    J Neurosci; 2001 Dec; 21(23):9414-8. PubMed ID: 11717374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.
    Cherner M; Suarez P; Casey C; Deiss R; Letendre S; Marcotte T; Vaida F; Atkinson JH; Grant I; Heaton RK;
    Drug Alcohol Depend; 2010 Jan; 106(2-3):154-63. PubMed ID: 19815352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.
    Wang GJ; Volkow ND; Chang L; Miller E; Sedler M; Hitzemann R; Zhu W; Logan J; Ma Y; Fowler JS
    Am J Psychiatry; 2004 Feb; 161(2):242-8. PubMed ID: 14754772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticolimbic dysregulation and chronic methamphetamine abuse.
    Baicy K; London ED
    Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?
    Veerasakul S; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
    Hum Psychopharmacol; 2016 May; 31(3):243-6. PubMed ID: 26913858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of longitudinal changes in cognition in individuals with methamphetamine use disorder during the first 6 weeks after commencing treatment.
    Fitzpatrick RE; Robinson AH; Rubenis AJ; Lubman DI; Verdejo-Garcia A
    Am J Drug Alcohol Abuse; 2021 May; 47(3):383-392. PubMed ID: 33524275
    [No Abstract]   [Full Text] [Related]  

  • 35. Attention and memory in illicit amphetamine users.
    McKetin R; Mattick RP
    Drug Alcohol Depend; 1997 Dec; 48(3):235-42. PubMed ID: 9449023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls.
    Rapeli P; Kivisaari R; Autti T; Kähkönen S; Puuskari V; Jokela O; Kalska H
    BMC Psychiatry; 2006 Feb; 6():9. PubMed ID: 16504127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained attention but not effort-based decision-making predicts treatment motivation change in people with methamphetamine dependence.
    Rubenis AJ; Fitzpatrick RE; Lubman DI; Verdejo-Garcia A
    J Subst Abuse Treat; 2018 Dec; 95():48-54. PubMed ID: 30352670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals.
    Kalechstein AD; De la Garza R; Newton TF; Green MF; Cook IA; Leuchter AF
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):254-8. PubMed ID: 19776303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is cognitive functioning impaired in methamphetamine users? A critical review.
    Hart CL; Marvin CB; Silver R; Smith EE
    Neuropsychopharmacology; 2012 Feb; 37(3):586-608. PubMed ID: 22089317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder.
    Rogers JM; Grant I; Marcondes MCG; Morgan EE; Cherner M; Ellis RJ; Letendre SL; Heaton RK; Iudicello JE
    J Int Neuropsychol Soc; 2024 Jan; 30(1):84-93. PubMed ID: 37553288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.